1. BACKGROUND

ILLINOIS POLLUTION CONTROL BOARD
November
2,
1989
ALLIED SIGNAL,
INC.
Petitioner,
V.
)
PCB 88—172
(Variance)
ILLINOIS ENVIRONMENTAL
)
PROTECTION AGENCY,
Respondent.
OPINION AND ORDER OF THE BOARD
(by M. Nardulli):
This matter comes before the Board on a petition for variance
filed October
21, 1988,
as amended on December
19,
1988 and as
amended again on February
21,
1989 by petitioner Allied—Signal,
Inc.
(“Allied”).
Allied seeks a one—year variance from
35
Ill.
Adm. Code 304.102 governing dilution of effluent
in wastewater
or,
in the alternative,
a one—year variance from 35
Ill.
Adm.
Code 304.124 governing the allowable concentration of arsenic
in
an effluent.
On April 18,
1989, Allied filed
its response to the
Agency’s Recommendation.
A hearing was held on April
20,
1989 at
which a member of the public attended and gave testimony.
Jan
Thomas of the Association of Concerned Environmentalist
(“ACE”)
expressed ACE’s objection to the variance and also raised
objections as
to the propriety of the hearing based on
allegations of lack
of notice.
By order
of the Board, ACE was
allowed to submit written questions for Allied’s witnesses who
were present at the April
20,
1989 hearing.
Allied submitted
written responses to these questions.
A second hearing was held
on August
25,
1989 to accommodate members of the public’s
concerns.
No members of the public attended this hearing.
On
August
21,
1989,
the Agency filed an Amended Recommendation
altering two of the conditions which the Agency recommended as
part of the variance.
BACKGROUND
Allied owns and operates
a facility
in Metropolis,
Illinois
which is engaged
in the production of uranium hexafluoride
(UF6)
and other fluoride compounds.
(Pet.
at par.
1.)
Allied
is one
of only two producers of UF6
in the country.
(Id.
at par.
3.)
UF6
is an essential element of the nuclear
fuel cycle which
supplies nuclear power plants
in the United States.
(Id.)
Allied employs approximately 365 persons and has
a total annual
payroll
in excess of $13 million.
1(~5 fl7

2
UF6
is
produced
from
uranium
ore
concentrates
which
are
received at the Metropolis
plant from various suppliers.
(Pet.
Exh.
A.)
Allied uses a unique fluoride volatility process in its
manufacture of UF6.
(Pet. at par.
4.)
An important part of this
process
involves
the reaction of
a prepared uranium
feed with
fluorine gas.
(Id.)
The fluorine gas is produced at the facility
by electrolyzing hydrofluoric acid
(HF).
(a.)
The HF used in
this
process
is
produced
at
a
separate
Allied
facility
from
fluorspar,
a naturally occurring mineral rich in calcium fluoride.
(Id.)
The
naturally
occurring
element
arsenic
is
present
in
fluorspar.
(~.
at par.
5.)
The arsenic remains as a contaminant
of the HF when the fluorspar is processed and enters the Metropolis
facility with the raw material HF.
(a.)
Arsenic also enters the
facility
as
a
component
of
the uranium
ore
concentrates
which
customers deliver to the plant for processing.
(j~.)
The level
of arsenic varies depending on the source of uranium ore.
(u.)
Additionally,
other
raw
materials
and
treating
agents
used
by
petitioner contain small amounts of arsenic.
(.i?~.)
The electrolyzation of the arthydrous hydrofluoric acid takes
place
in
closed
vessels
in
the
presence
of
an
electrolyte
or
“melt.”
(Id. at par.
6.)
Periodically,
it is necessary to replace
the
spent
melt.
(Id.)
Allied
directs
spent
melt
to
its
Environmental Protection Facility
(“EPF”).
(~.)
The treated
effluent is discharged into the Ohio River under NPDES Permit No.
1L0004421.
(Id.)
Allied’s
current
NPDES
permit
contains
no
effluent limitation for arsenic, but requires Allied to monitor and
report arsenic concentrations to the Agency monthly.
(~.
at 8.)1
Sampling for arsenic is
performed at
a point before mixing with
Allied’s other wastestreams occurs.
(Id.)
The
results
of this
monitoring typically indicated arsenic concentrations in the range
of 0.02 to 0.30 mg/l,
a range acceptable under
35
Ill.
Adm.
Code
304.124(a).
(Id.
at par.
9.)
In the
summer
of
1988,
after
submitting
its NPDES
renewal
application,
Allied performed arsenic
tests
in
its wastestream.
(Id. at par.
9; Presubmitted testimony of Larry Bruce at par.
5 and
J.E.
Honey
at
par.
9.)
These
test
results
indicated
arsenic
concentrations
significantly
greater
than
the
typical
range
previously found by Allied and those levels found by the Agency in
its own compliance monitoring of Allied’s wastewater discharge.
(~.)
This
discrepancy
resulted
from
Allied’s
use
of
a
more
aggressive wastewater testing procedure than that used by Allied’s
previous independent labs testing and by the Agency.
(u.)
Allied
reported the results
of this testing
to the Agency
and began
a
1Although Allied’s permit was due to expire on July
1,
1988,
the
permit
remains
in
effect
because
Allied
made
a
timely
application for renewal.
(Ill.
Rev. Stat. 1987,
ch. 111 1/2, par.
1012(f).)

3
program
of
continued
analysis and evaluation
of arsenic
in
its
wastestream.
(u.)
Additional
investigations
established
the
presence
cf
an
extremely
rare
and highly
stable
form
of
arsenic,
(AsF6)
,
or
hexafluoroarsenate.
(Id.
at par.
10;
Bruce
at par.
7;
Honey
at
par.
10.)
On
September
30,
1988,
the Agency
issued
Allied
an
NPDES
permit containing an effluent limitation for arsenic and requiring
Allied to monitor arsenic at a point upstream from other controlled
parameters.
The
levels
of
arsenic
present
in
the
form
of
hexafluoroarsenate
in Allied’s discharge result
in violations
of
the new permit standard for arsenic.
(~.
at par.
11.)
Allied’s
NPDES permit became effective December 31, 1988.
(Pet. attachment
F.)
RELIEF REQUESTED
Allied
seeks
a
one-year variance
from
35
Ill.
Adin.
Code
304.102
which
provides that
dilution
of the
effluent
from
any
wastewater
source
is not acceptable
as
a method of treatment
of
wastes in order to meet the arsenic standard set forth in 35
Ill.
Adrn.
Code
304.124.
“Rather,
it
shall
be
the obligation
of any
persons discharging contaminants of any kind
in to the waters of
the state to provide the best degree
of treatment of wastewater
consistent with technological feasibility, economic reasonableness
and sound engineering judgment.”
(35 Ill. Adm.
Code 304.102(a).)
Section
304.102(b)
further
provides
that
“measurement
of
contaminant
concentrations
to
determine
compliance
with
the
effluent standards shall be made at the point immediately following
the final treatment process and before mixture with other waters,
unless another point is designated by the Agency in an individual
permit
...
.“
(35 Ill.
Adm.
Code
304.102(b).)
Allied requests
that
it be allowed to comply with the 0.25
ing/l
arsenic effluent
limitation
by
measuring
the
concentration
of
arsenic
at
the
facility’s final outfall
(002),
or by allowing Allied to monitor
compliance by calculating the arsenic effluent concentration at the
EPF which takes into account the mixing of Allied’s EPF wastestream
with other wastewaters before discharge into the Ohio River.
(Pet.
at par.
6.)
Alternatively, Allied seeks a one—year variance from
the 0.25 mg/l arsenic effluent limitation set forth in
35 Ill. Adm.
Code 304.124
as measured at the EPF outfall,
before mixing with
other wastewaters,
to allow Allied to meet, a 4.5 mg/l limitation.
COMPLIANCE
PLAN
Allied
maintains
that
information
about
the
chemistry
or
treatability
of
the
hexafluoroarsenate
ion
is
virtually
non-
existent
since
few
other
manufacturing
processes
result
in
generation of this ion.
(Pet.
at par.
12; presubinitted testimony
of
Dr.
William
E. Rinehart
at par.
3.)
Dr. Howell
R.
Clark,
a
105—09

4
chemist
retained
by
Allied
to
assess,
inter
alia,
whether
hexafluoroarsenate could be removed by the application of current
technology (without regard to economic feasibility) testified that
very
little
hexafluoroarsenate
was
being
removed
from
the
wastewater
at
either EPF
outfall.
(Presubmitted
testimony
of
Howell R. Clark at par.
6(D).)
According to Clark, the only means
of decomposing hexafluoroarsenate is to apply a combination of high
heat and concentrated acid.
(Id. at par. 7(A).)
After discussing
this
theoretical
treatment
system,
Clark
testified
that
the
compound resulting from such treatment
(Ca3
(ASO4)2) would be
far
more toxic than the hexafluoroarsenate itself.
(id. at par.
9.)
Allied
believes
that
there
is
no
existing
demonstrated
technology
for
the
practical
treatment
of
hexafluoroarsenate.
Therefore,
Allied’s
compliance plan
is,
in
essence,
a
plan to
research and investigate methods of dealing effectively with the
hexafluoroarsenate.
Allied has instituted
a two-phase
study to
address this contamination.
(Pet. at par. 13.)
Phase one consists
of an arsenic material balance investigation to adequately confirm
the source of the hexafluoroarsenate.
(Id.)
Phase two consists
of
a treatability
study
to assess
the technical feasibility and
economic reasonableness
of treatment of the
contaminant.
(Id.)
In
an
effort to minimize the arsenic
concentration,
Allied has
identified
a
source
of
low
arsenic
hydrofluoric
acid
and
is
obtaining all of the hydrofluoric acid needed at the facility from
this facility.
(Ic~.
at par.
14.)
The Agency recognizes that Allied has not submitted a concrete
compliance plan but suggests that the unique circumstances of this
cause warrant an exception from the compliance plan requirement (35
Ill.
Adm. Code 104.121(f)).
The Agency agrees that further
study
is needed.
(Agency Rec.
at par.
19.)
In particular,
the Agency
seeks
to determine the
best degree
of treatment for
arsenic
at
Allied’s facility.
(la.)
The
Board
has
recognized
that
some
factual
circumstances
prompt some flexibility regarding the compliance plan requirement.
(Anderson Clayton Foods v.
IEPA,
PCB 84—147
(January 24,
1985).)
The
Board
has granted
a variance
in
the absence of
a
concrete
compliance plan where more information regarding new technology
needed to be gathered in order to recommend methods of compliance.
(u.)
Similarly,
the
Board
has
found
that
research
aimed
at
finding
a
means
of compliance may justify a
short—term variance
(Mobil Oil
Co.
v.
IEPA,
PCB 84—37
(September 20,
1984).)
The Board
concludes
that,
under
the
instant circumstances
where
a
new
permit
condition
has
been
imposed
and
where
no
demonstrated
technology
exists
for
achieving
compliance,
the
granting a short-term variance is justified.
Allied has submitted
ample evidence of the unique nature of hexafluoroarsenate and the
lack of available data and literature on means
of removing the
contaminant from wastewater.
Moreover, the parties agree that it
105”10

5
is not reasonable to expect Allied to immediately comply with the
arsenic effluent limitation.
HARDSHIP
AND
ENVIRONMENTAL
IMPACT
Allied asserts that it will incur an arbitrary or unreasonable
hardship
if it
is required to immediately comply with the arsenic
effluent limitation
(35 Ill.
Adm.
Code 304.124) at its EPF outfall
because
Allied
would
be
required
to
substantially
curtail
or
possibly
cease
its
manufacturing
activity
at
the
Metropolis
facility.
(Pet. at par.
19.)
Allied also notes that,
if it ceases
operations,
the community
of Metropolis
and
the
nuclear
energy
industry would also suffer hardship.
(~.)
The Agency agrees that the facility’s fluorine process would
have to shut down in order to achieve immediate compliance with the
arsenic
effluent
limitation.
(Agency
Rec.
at
par.
21.)2
The
Agency states that,
in the absence of a presently known treatment
technology
to control
the amount of
arsenic discharged
from the
facility, there is no alternative to compliance other than shutting
down the
operation.
(~.)
Therefore,
the Agency
agrees
that
immediate
compliance
would
impose
an
arbitrary
or unreasonable
hardship on Allied.
(~.)
According
to
Allied,
the
concentration
of
arsenic
in
its
discharge to the Ohio River from its 002 outfall would consistently
fall below
0.25 mg/l as provided for in 35 Ill. Adm. Code 304.124.
(Pet. at par.
9; presubmitted testimony of Larry Bruce at par.
22.)
Because
of
the very
high
level
of
flow
of
the
Ohio
River
at
Metropolis, Allied asserts that allowing its discharge to continue
at current levels for the period of the variance will not result
in a violation of the Board’s arsenic water quality standards
(35
Ill.
Adm.
Code 302.2089).~
In support of
its assertion that the
requested variance would result in minimal adverse
environmental
impact, Allied introduced the testimony of Dr. William E. Rinehart,
a toxicologist.
Rinehart testified that hexafluoroarsenate does
not exhibit the level of toxicity noted for other arsenic compounds
because the former ion is so stable that it is not converted by the
body to the more toxic oxygenated forms of arsenic.
(Presubmitted
testimony at par.
5~)4 Rinehart concluded that the presence of
2The Agency notes that Allied has appealed the NPDES permit
conditions and that Section 16(b)
of the Administrative Procedure
Act stays the contested condition pending resolution of the appeal.
3Allied also notes that it would also be in compliance with
the Board’s proposed amendment to 302.208
(see R88—2l).
4Dr.
Howell
R.
Clark,
a chemist-consultant,
testified
as to
the unique stability of the hexafluoroarsenate ion.
(Presubmitted
testimony at par.
7(A).)
1q5-11

6
hexafluoroarsenate in Allied’s effluent should not be equated with
concerns over the presence
of
other
arsenic
ions
and that
the
presence
of
hexafluoroarsenate
in
the concentrations
indicated
would not lead to an appreciable toxic hazard to the environment.
(~.
at par.
10.)
The Agency states in its Recommendation that the high dilution
ratio
of Allied’s
discharge
to the Ohio River,
the
short
time
period
of
the
requested
variance
and
the
absence
of
any
public
water
supply
intakes
until
40
miles
downstream
of
Allied’s
Metropolis facility support the conclusion that the variance will
not
result
in
any
significant
adverse
environmental
impact.
(Agency Rec.
at par.
16.)
Based upon
the
foregoing,
the Board
finds that Allied
has
presented adequate proof that immediate compliance with the arsenic
effluent
limitation
would
impose
an
arbitrary
and
unreasonable
hardship upon Allied and that granting the variance will not result
in any significant adverse environmental impact.
COMPLIANCE WITH
FEDERAL
LAW
The Agency states that there are no federal arsenic effluent
limitations governing Allied’s discharge
and that the requested
variance may be granted consistent with federal law.
CONCLUSION
In view of the hardship demonstrated,
as well as the minimal
environmental
impact expected during the
term of
the requested
variance, the Board finds that adequate proof has been demonstrated
that
immediate
compliance
with
the
arsenic
effluent
limitation
would
impose
an
arbitrary or unreasonable hardship upon Allied.
The
Agency
recommends
that
Allied
be
granted
the
requested
alternate variance from the arsenic effluent limitation
(35 Ill.
Adm.
Code 304.124)
subject to certain conditions. The Agency does
not recommend that Allied be granted a variance from the dilution
rule
(35 Ill. Adm. Code 304.102) because the information submitted
by Allied does not establish that Allied’s treatment works provides
the “best degree
of
treatment”
for meeting the arsenic effluent
standard.
(See,
35 Ill. Adni. Code 304.102(a).)
Indeed,
it appears
that data concerning the unique hexafluoroarsenate ion is scarce.
The Board agrees with the Agency
and conclude that the variance
will
be granted
from
35
Ill.
Adm.
Code
304.124
subject
to
the
conditions
recommended
by
the
Agency,
including
those
two
conditions subsequently
amended,
as outlined in the Order below.
We note that this variance
is retroactive to June
22,
1989,
the
date which the Board would have had to render its decision if their
had not been improper notice of hearing.
Additionally, the Board
has extended the length of the variance an additional 120 days with
the requirement that Allied submit its engineering evaluation and
105-42

7
petition for extension of variance no later than 120 days prior to
the expiration of this variance.
This
Opinion
constitutes
the
Board’s
findings
of
fact
and
conclusions of law
in this matter.
ORDER
Allied
Signal,
Inc.
is
hereby granted
a variance
from the
arsenic effluent limitation set forth at 35 Ill. Adm. Code 304.124
for its Metropolis
facility subject to the following conditions:
1.
This variance begins June 22,
1989 and expires
February 17,
1991;
2.
Allied
shall
conduct
a
comprehensive
engineering evaluation of the treatability of
arsenic from its facility including the effect
of process changes, improved housekeeping, and
waste
component
recovery
and
reuse
with
economic
estimates
for
each
option.
This
evaluation
shall be due
120 days before the
end of the variance granted herein;
3.
Together
with
the
engineering
evaluation,
Allied shall submit a
petition to extend the
variance which includes a complete compliance
plan as required by Section 104.121(f);
4.
Allied shall
make interim quarterly progress
reports to the Agency during the term of this
variance;
These interim progress reports should be sent
to:
Illinois Environmental Protection Agency
Compliance Assurance Section
Division of Water Pollution Control
ATTN:
Ms. Barb Conner
2200 Churchill Road
Springfield,
IL 62794—9276
5.
Allied shall conduct the following two-phase
bioassay test:
a.
As
a
first
phase,
Allied
shall
perform
a
96
hour
acute
static
bioassay
on
minnows
with
samples
that
contain
several
concentration
levels
of
potassium
hexafluoroarsenate.
The purpose of
105-13

8
this
test
should
be
to
statistically
determine
the
LC5O
for
the
hexafluoroarsenate
ion.
If
the
LC5O
of
this
ion
is
greater
than
or
equal
to
25
times
higher
than
the
LCSO
for
pentavalent arsenic oxide
as shown
in
the
literature,
no
further
chronic
or
bioaccumulation
testing
should
be
required.
b.
If
the
LC5O
of
hexafluoroarsenate
is
less
than
25
times higher than the
LC5O
of
pentavalent
arsenic
oxide
as
determined
under
(a)
,
above,
petitioner shall perform a Phase II
early
life
stage
(28
days
post—
hatch)
bioassay
of
the
chronic
toxicity
and
bioaccumulations
potential
of
hexafluoroarsenate.
The test
should be performed
as
a
single,
combined test
of both
the
chronic and bioaccumulative effects
of
a
prepared
effluent
sample
on
minnows.
The
prepared
effluent
sample
should
be
made
up
of
concentrations
of
potassium
hexafluoroarsenate
and pentavalent
arsenic
oxide
in
a
ratio
that
is
consistent
with
the
ratio
of
hexafluoroarsenate and conventional
arsenic forms
in the effluent from
Allied’s
final
outfall
002.
These
samples
should
include
one
at
the
arsenic levels
found
in the actual
effluent
from
002,
and
at
5
times
that level, and one at 10 times that
level.
6.
During the variance period, Allied shall limit
its discharge
of
arsenic
as
measured by the
aggressive
digestion
protocol
at
its
EPF
outfall
to
8.1
lbs/day
monthly
average
and
16.2
lbs/day
maximum
daily
average.
The
combined discharge shall not exceed 0.25 mg/l;
7.
All other uncontested provisions of the NPDES
permit shall be followed,
including reporting
of load and concentration units;
8.
Allied must execute and send a certification
of acceptance within
45
days of the date
of
this Order to the following address:
105.-IA

9
Illinois
Environmental
Protection
Agency
ATTN:
Pat
Lindsay
Division
of
Water
Pollution
Control
Compliance Assurance Section
2200 Churchill Road
P.O. Box 19276
Springfield,
IL 62794—9276
IT IS SO ORDERED.
Section
41
of
the
Illinois
Environmental
Protection
Act
provides for appeal of final orders of the Board within 35 days.
(Ill.
Rev. Stat.
1987,
ch.
111 1/2,
par.
1041.)
The Rules of the
Supreme Court of Illinois establish filing requirements.
I,
Dorothy N.
Gunn,
Clerk of the Illinois Pollution
Control
Board
hereby’ certify th~ the above Opinion and Order was adopted
on the ~
day of
~
,
1989 by a vote of
~‘°
~,
Dorothy M.Aunn,
Clerk
Illinois Pollution Control Board
10515

Back to top